BlackRock lowers stake in Novo Nordisk

Jun. 16, 2022 6:16 AM ETNovo Nordisk A/S (NVO), BLKBy: Ravikash, SA News Editor1 Comment

Novo Nordisk Canada Inc head office in Mississauga, Ontario, Canada.

JHVEPhoto/iStock Editorial via Getty Images

  • Novo Nordisk (NVO) said on June 7 that it was notified by BlackRock (NYSE:BLK) that as of May 31, the asset manager owned less than 5% of share capital of Novo.
  • This down from the 5% stake which BlackRock held as of April 27, according to Novo's May 2 release.
  • The Denmark-based diabetes-focused drugmaker said that as of May 31, BlackRock held B shares equal to below 5% of the company's entire share capital.
  • The total B shares held by Blackrock now correspond to below 5% of the entire share capital and below 5% of the voting rights, Novo noted.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.